Loss of glutathione peroxidase 3 expression is correlated with epigenetic mechanisms in endometrial adenocarcinoma

Cancer Cell International

Volumn 10, Issue , 2010, Pages

  Falck, Eva ^a   Karlsson, Sandra ^a   Carlsson, Jessica ^a   Helenius, Gisela ^b   Karlsson, Mats ^b   Klinga Levan, Karin ^a  

^a UNIVERSITY OF SKÖVDE   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE PEROXIDASE 3; SCATTER FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; CANCER GRADING; DISEASE ASSOCIATION; DOWN REGULATION; ENDOMETRIUM CARCINOMA; EPIGENETICS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; METHYLATION; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION;

EID: 78549258157     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-10-46     Document Type: Article

References (30)

1. Prat J. Prognostic parameters of endometrial carcinoma. Hum Pathol 2004, 35(6):649-662. 10.1016/j.humpath.2004.02.007, 15188130.
2. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecologic Oncology 1983, 15:10-17. 10.1016/0090-8258(83)90111-7, 6822361.
3. Deligdisch L, Holinka CF. Endometrial carcinoma: two diseases?. Cancer Detection and Prevention 1987, 10(3-4):237-246.
4. Lax SF, Kurman RJ. A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses. Verh Dtsch Ges Pathol 1997, 81:228-232.
5. Greven KM, Corn BW. Endometrial cancer. Curr Probl Cancer 1997, 21(2):65-127. 10.1016/S0147-0272(97)80002-5, 9128804.
6. Deerberg FKJ. Endometrial Carcinoma in BDII/Han rats: model of a spontaneous hormone-dependent tumor. J Natl Cancer Inst 1987, 78:1245-1251.
7. Kaspareit-Rittinghausen J, Deerberg F, Rapp K. Mortality and incidence of spontaneous neoplasms in BDII/Han rats. Z Versuchstierkd 1987, 30(5-6):209-216.
8. Vollmer G. Endometrial cancer: experimental models useful for studies on molecular aspects of endometrial cancer and carcinogenesis. Endocr Relat Cancer 2003, 10(1):23-42. 10.1677/erc.0.0100023, 12653669.
9. Karlsson S, Olsson B, Klinga-Levan K. Gene expression profiling predicts a three-gene expression signature of endometrial adenocarcinoma in a rat model. Cancer Cell Int 2009, 9:12. 10.1186/1475-2867-9-12, 2687412, 19426485.
10. Karlsson JOG, Sjöstedt A, Wahlström J, Axelsson KL, Andersson RGG. Cyclic guanosine monophosphate metabolism in human amnion cells trisomic for chromosome 21. Biology of the Neonate 1990, 57:343-348. 10.1159/000243211, 2164849.
11. Saga Y, Ohwada M, Suzuki M, Konno R, Kigawa J, Ueno S, Mano H. Glutathione peroxidase 3 is a candidate mechanism of anticancer drug resistance of ovarian clear cell adenocarcinoma. Oncol Rep 2008, 20(6):1299-1303.
12. Yu YP, Yu G, Tseng G, Cieply K, Nelson J, Defrances M, Zarnegar R, Michalopoulos G, Luo JH. Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis. Cancer Res 2007, 67(17):8043-8050. 10.1158/0008-5472.CAN-07-0648, 17804715.
13. Lodygin D, Epanchintsev A, Menssen A, Diebold J, Hermeking H. Functional epigenomics identifies genes frequently silenced in prostate cancer. Cancer Res 2005, 65(10):4218-4227. 10.1158/0008-5472.CAN-04-4407, 15899813.
14. Zhang X, Yang JJ, Kim YS, Kim KY, Ahn WS, Yang S. An 8-gene signature, including methylated and down-regulated glutathione peroxidase 3, of gastric cancer. Int J Oncol 2010, 36(2):405-414.
15. Jee CD, Kim MA, Jung EJ, Kim J, Kim WH. Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma. Eur J Cancer 2009, 45(7):1282-1293. 10.1016/j.ejca.2008.12.027, 19195878.
16. Lee OJ, Schneider-Stock R, McChesney PA, Kuester D, Roessner A, Vieth M, Moskaluk CA, El-Rifai W. Hypermethylation and loss of expression of glutathione peroxidase-3 in Barrett's tumorigenesis. Neoplasia 2005, 7(9):854-861. 10.1593/neo.05328, 1501938, 16229808.
17. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003, 4(12):915-925. 10.1038/nrm1261, 14685170.
18. Rong S, Segal S, Anver M, Resau JH, Vande Woude GF. Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc Natl Acad Sci USA 1994, 91(11):4731-4735. 10.1073/pnas.91.11.4731, 43862, 8197126.
19. Taulli R, Scuoppo C, Bersani F, Accornero P, Forni PE, Miretti S, Grinza A, Allegra P, Schmitt-Ney M, Crepaldi T, et al. Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma. Cancer Res 2006, 66(9):4742-4749. 10.1158/0008-5472.CAN-05-4292, 16651427.
20. Lutterbach B, Zeng Q, Davis LJ, Hatch H, Hang G, Kohl NE, Gibbs JB, Pan BS. Lung cancer cell lines harboring MET gene amplification are dependent on Met for growth and survival. Cancer Res 2007, 67(5):2081-2088. 10.1158/0008-5472.CAN-06-3495, 17332337.
21. Takayama H, LaRochelle WJ, Sharp R, Otsuka T, Kriebel P, Anver M, Aaronson SA, Merlino G. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci USA 1997, 94(2):701-706. 10.1073/pnas.94.2.701, 19577, 9012848.
22. Wang R, Ferrell LD, Faouzi S, Maher JJ, Bishop JM. Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice. J Cell Biol 2001, 153(5):1023-1034. 10.1083/jcb.153.5.1023, 2174327, 11381087.
23. Schmidt L, Junker K, Nakaigawa N, Kinjerski T, Weirich G, Miller M, Lubensky I, Neumann HP, Brauch H, Decker J, et al. Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Oncogene 1999, 18(14):2343-2350. 10.1038/sj.onc.1202547, 10327054.
24. Bottaro DP, Rubin JS, Faletto DL, Chan AM-L, Kmiecik TE, Vande Woude GF, Aaronson SA. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991, 251:802-804. 10.1126/science.1846706, 1846706.
25. Gentile A, Trusolino L, Comoglio PM. The Met tyrosine kinase receptor in development and cancer. Cancer Metastasis Rev 2008, 27(1):85-94. 10.1007/s10555-007-9107-6, 18175071.
26. Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 1991, 51(3):794-798.
27. Nordlander C, Karlsson S, Karlsson A, Sjoling A, Winnes M, Klinga-Levan K, Behboudi A. Analysis of chromosome 10 aberrations in rat endometrial cancer-evidence for a tumor suppressor locus distal to Tp53. Int J Cancer 2007, 120(7):1472-1481. 10.1002/ijc.22533, 17245700.
28. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, Schumacker PT. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci USA 1998, 95(20):11715-11720. 10.1073/pnas.95.20.11715, 21706, 9751731.
29. Helou K, Walentinsson A, Beckmann B, Johansson T, Hedrich HJ, Szpirer C, Klinga-Levan K, Levan G. Analysis of genetic changes in rat endometrial carcinomas by means of comparative genome hybridization. Cancer Genet Cytogenet 2001, 172(2):118-127.
30. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002, 18(11):1427-1431. 10.1093/bioinformatics/18.11.1427, 12424112.